Alfonso Brito

1.0k total citations
20 papers, 735 citations indexed

About

Alfonso Brito is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Alfonso Brito has authored 20 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Biomedical Engineering. Recurrent topics in Alfonso Brito's work include CAR-T cell therapy research (17 papers), Nanowire Synthesis and Applications (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Alfonso Brito is often cited by papers focused on CAR-T cell therapy research (17 papers), Nanowire Synthesis and Applications (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Alfonso Brito collaborates with scholars based in United States, Brazil and China. Alfonso Brito's co-authors include Renate Starr, Christine E. Brown, Stephen J. Forman, Brenda Aguilar, Aniee Sarkissian, Julie R. Ostberg, Dongrui Wang, Darya Alizadeh, Behnam Badie and Wen-Chung Chang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Alfonso Brito

20 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfonso Brito United States 6 588 254 245 225 128 20 735
Yubo Zhai United States 5 542 0.9× 246 1.0× 227 0.9× 192 0.9× 176 1.4× 8 721
Vita S. Salsman United States 6 535 0.9× 154 0.6× 279 1.1× 159 0.7× 110 0.9× 9 660
Aniee Sarkissian United States 5 466 0.8× 224 0.9× 194 0.8× 145 0.6× 117 0.9× 8 575
Johanna Theruvath United States 8 390 0.7× 179 0.7× 318 1.3× 223 1.0× 104 0.8× 22 714
Skyler P. Rietberg United States 7 779 1.3× 297 1.2× 309 1.3× 324 1.4× 175 1.4× 9 1.0k
Megan M. Davis United States 12 804 1.4× 230 0.9× 288 1.2× 493 2.2× 51 0.4× 28 1.1k
Sunitha Kakarla United States 9 936 1.6× 296 1.2× 403 1.6× 274 1.2× 58 0.5× 13 1.1k
Zhongzhen Yi United States 11 1.0k 1.8× 418 1.6× 459 1.9× 283 1.3× 145 1.1× 17 1.2k
Kevin Chow United States 11 982 1.7× 382 1.5× 416 1.7× 270 1.2× 172 1.3× 16 1.2k
Darya Alizadeh United States 13 942 1.6× 393 1.5× 514 2.1× 417 1.9× 188 1.5× 25 1.3k

Countries citing papers authored by Alfonso Brito

Since Specialization
Citations

This map shows the geographic impact of Alfonso Brito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Brito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Brito more than expected).

Fields of papers citing papers by Alfonso Brito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso Brito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Brito. The network helps show where Alfonso Brito may publish in the future.

Co-authorship network of co-authors of Alfonso Brito

This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso Brito. A scholar is included among the top collaborators of Alfonso Brito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso Brito. Alfonso Brito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brito, Alfonso, et al.. (2024). ATA3431: Allogeneic CD19/CD20 Bispecific CAR EBV T Cells for the Treatment of B-Cell Malignancies. Transplantation and Cellular Therapy. 30(2). S11–S11. 2 indexed citations
2.
Brito, Alfonso, et al.. (2023). ATA3431: Allogeneic CD19/CD20 Bispecific CAR EBV T Cells for the Treatment of B-Cell Malignancies. Blood. 142(Supplement 1). 4800–4800. 1 indexed citations
3.
Starr, Renate, Brenda Aguilar, Diana Gumber, et al.. (2022). Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells. Cancer Research Communications. 3(1). 66–79. 7 indexed citations
4.
Wang, Dongrui, Briana C. Prager, Ryan C. Gimple, et al.. (2020). CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies. Cancer Discovery. 11(5). 1192–1211. 121 indexed citations
5.
Wang, Dongrui, Jana Portnow, Vivian Chiu, et al.. (2020). Abstract A52: Systemic anti-PD-1 immunotherapy results in PD-1 blockade on T cells in the cerebrospinal fluid. Cancer Immunology Research. 8(3_Supplement). A52–A52. 1 indexed citations
6.
Liu, Jiangyue, Xianhui Chen, Alfonso Brito, et al.. (2020). 98 ATA3271: an armored, next-generation off-the-shelf, allogeneic, mesothelin-CAR T cell therapy for solid tumors. SHILAP Revista de lepidopterología. A61.2–A62. 4 indexed citations
7.
Spindler, Tassja J., et al.. (2020). ATA3219: A Potent Next-Generation Allogeneic Off-the-Shelf CD19-CAR T Therapy without the Need for Gene-Editing. Blood. 136(Supplement 1). 9–9. 1 indexed citations
8.
Portnow, Jana, Dongrui Wang, M. Suzette Blanchard, et al.. (2020). Systemic Anti–PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid. JAMA Oncology. 6(12). 1947–1947. 31 indexed citations
9.
Wang, Dongrui, Renate Starr, Wen-Chung Chang, et al.. (2020). Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma. Science Translational Medicine. 12(533). 163 indexed citations
10.
Barish, Michael E., Lihong Weng, Massimo D’Apuzzo, et al.. (2020). P855 High-resolution maps of heterogeneous antigen expression in glioblastoma and implications for immunotherapy. Poster presentations. A6.1–A6. 1 indexed citations
11.
12.
Wang, Dongrui, Alfonso Brito, Darya Alizadeh, et al.. (2019). Abstract 2321: Dual-function of CD27-CD70 costimulatory signal in CAR T cell therapy. Cancer Research. 79(13_Supplement). 2321–2321. 2 indexed citations
13.
Wang, Dongrui, Brenda Aguilar, Renate Starr, et al.. (2018). Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity. JCI Insight. 3(10). 162 indexed citations
14.
Portnow, Jana, Timothy W. Synold, Vivian Chiu, et al.. (2018). ATIM-17. PEMBROLIZUMAB BLOCKS PD-1 ON CAR T CELLS ADMINISTERED INTRAVENTRICULARLY TO GLIOBLASTOMA PATIENTS. Neuro-Oncology. 20(suppl_6). vi4–vi4. 1 indexed citations
15.
Wang, Xiuli, Christian Huynh, Ryan Urak, et al.. (2018). The Cerebroventricular Environment Reprograms Locally Infused CAR T Cells for Superior Activity Against Both CNS and Systemic B Cell Lymphoma. Blood. 132(Supplement 1). 965–965. 3 indexed citations
16.
Brown, Christine E., Brenda Aguilar, Renate Starr, et al.. (2017). Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma. Molecular Therapy. 26(1). 31–44. 226 indexed citations
17.
Wang, Dongrui, Sarah Wright, Wen-Chung Chang, et al.. (2017). IMMU-08. THERAPEUTIC POTENTIAL OF CHLOROTOXIN-REDIRECTED CAR-T CELLS AGAINST HETEROGENEOUS GLIOBLASTOMAS. Neuro-Oncology. 19(suppl_6). vi114–vi114. 2 indexed citations
18.
Murad, John P., Dileshni Tilakawardane, Brenda Aguilar, et al.. (2016). 204. HER2-Specific Chimeric Antigen Receptor T Cells for the Treatment of Breast-to-Brain Metastasis. Molecular Therapy. 24. S79–S80. 1 indexed citations
19.
Brown, Christine E., Renate Starr, Brenda Aguilar, et al.. (2015). Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma. Journal for ImmunoTherapy of Cancer. 3(S2). 4 indexed citations
20.
Gonzalez, Eileen R, Alfonso Brito, Lila Peltekian, et al.. (2013). Mitochondrial Dynamics in the Type 2 Diabetic Heart. The FASEB Journal. 27(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yubo Zhai Breakdown of academic impact, for papers by Vita S. Salsman Breakdown of academic impact, for papers by Aniee Sarkissian Breakdown of academic impact, for papers by Johanna Theruvath Breakdown of academic impact, for papers by Skyler P. Rietberg Breakdown of academic impact, for papers by Megan M. Davis Breakdown of academic impact, for papers by Sunitha Kakarla Breakdown of academic impact, for papers by Zhongzhen Yi Breakdown of academic impact, for papers by Kevin Chow Breakdown of academic impact, for papers by Darya Alizadeh
Rankless by CCL
2026